Daybree

trofinetide · ACADIA Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Daybree, covering 2024-09-27 to 2024-09-27. Get the full timeline:

Most recent: Clinical Trial Update: Open-Label Extension Study of Trofinetide for Rett Syndrome [Phase 3]